Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties
Decker, Michael, Kraus, Birgit and Heilmann, Jörg (2008) Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties. Bioorganic & medicinal chemistry 16 (8), pp. 4252-4261.Date of publication of this fulltext: 18 Oct 2010 13:28
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Bioorganic & medicinal chemistry | ||||
| Publisher: | Elsevier | ||||
|---|---|---|---|---|---|
| Volume: | 16 | ||||
| Number of Issue or Book Chapter: | 8 | ||||
| Page Range: | pp. 4252-4261 | ||||
| Date | 2008 | ||||
| Additional Information (public) | CAN 149:464 1-3 Pharmacology 9000-81-1 (Acetylcholinesterase) Role: BSU (Biological study, unclassified), BIOL (Biological study) (hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties); 1029034-02-3P; 1029034-03-4P; 1029034-04-5P; 1029034-05-6P; 1029034-06-7P; 1029034-07-8P; 1029034-08-9P; 1029034-09-0P; 1029034-10-3P; 1029034-11-4P; 1029034-12-5P; 1029034-13-6P; 1029034-14-7P; 1029034-15-8P Role: PAC (Pharmacological activity), SPN (Synthetic preparation), THU (Therapeutic use), BIOL (Biological study), PREP (Preparation), USES (Uses) (hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties); 745837-16-5; 911366-60-4 Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties); 109-76-2 (1,3-Propanediamine); 110-60-1 (1,4-Butanediamine); 124-09-4 (1,6-Hexanediamine); 373-44-4 (1,8-Octanediamine); 462-94-2 (1,5-Pentanediamine); 646-19-5 (1,7-Heptanediamine); 1200-22-2 (Lipoic acid); 881890-07-9; 911366-48-8 Role: RCT (Reactant), RACT (Reactant or reagent) (hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties); 9001-08-5 (Butyrylcholinesterase) Role: BSU (Biological study, unclassified), BIOL (Biological study) (inhibitors; hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties) | ||||
| Institutions | Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical Biology (Prof. Heilmann) | ||||
| Identification Number |
| ||||
| Keywords | Antioxidants Cholinesterase inhibitors Structure-activity relationship (hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties) butyrylcholinesterase inhibitor antioxidant quinazolinimine lipoate prepn SAR | ||||
| Dewey Decimal Classification | 500 Science > 570 Life sciences 500 Science > 540 Chemistry & allied sciences | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 17237 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric